Morris M - Search Results

1

Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC).

Levenback C, Burke TW, Silva E, Morris M, Gershenson DM, Kavanagh JJ, Wharton JT. Levenback C, et al. Among authors: morris m. Gynecol Oncol. 1992 Sep;46(3):317-21. doi: 10.1016/0090-8258(92)90224-7. Gynecol Oncol. 1992. PMID: 1526508

2

Treatment of small cell carcinoma of the cervix with cisplatin, doxorubicin, and etoposide.

Morris M, Gershenson DM, Eifel P, Silva EG, Mitchell MF, Burke TW, Wharton JT. Morris M, et al. Gynecol Oncol. 1992 Oct;47(1):62-5. doi: 10.1016/0090-8258(92)90077-v. Gynecol Oncol. 1992. PMID: 1330847 Clinical Trial.

3

The effect of prolonged cisplatin-based chemotherapy on progression-free survival in patients with optimal epithelial ovarian cancer: "maintenance" therapy reconsidered.

Gershenson DM, Mitchell MF, Atkinson N, Silva EG, Kavanagh JJ, Morris M, Burke TW, Warner D, Wharton JT. Gershenson DM, et al. Among authors: morris m. Gynecol Oncol. 1992 Oct;47(1):7-13. doi: 10.1016/0090-8258(92)90067-s. Gynecol Oncol. 1992. PMID: 1427404 Clinical Trial.

4

Minimally invasive vulvar carcinoma: an indication for conservative surgical therapy.

Kelley JL 3rd, Burke TW, Tornos C, Morris M, Gershenson DM, Silva EG, Wharton JT. Kelley JL 3rd, et al. Among authors: morris m. Gynecol Oncol. 1992 Mar;44(3):240-4. doi: 10.1016/0090-8258(92)90050-s. Gynecol Oncol. 1992. PMID: 1541436

5

Pelvic exenteration in the elderly patient.

Matthews CM, Morris M, Burke TW, Gershenson DM, Wharton JT, Rutledge FN. Matthews CM, et al. Among authors: morris m. Obstet Gynecol. 1992 May;79(5 ( Pt 1)):773-7. Obstet Gynecol. 1992. PMID: 1565364

6

Superficially invasive squamous cell carcinoma of the cervix.

Copeland LJ, Silva EG, Gershenson DM, Morris M, Young DC, Wharton JT. Copeland LJ, et al. Among authors: morris m. Gynecol Oncol. 1992 Jun;45(3):307-12. doi: 10.1016/0090-8258(92)90310-f. Gynecol Oncol. 1992. PMID: 1612508

7

Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin.

Gershenson DM, Morris M, Cangir A, Kavanagh JJ, Stringer CA, Edwards CL, Silva EG, Wharton JT. Gershenson DM, et al. Among authors: morris m. J Clin Oncol. 1990 Apr;8(4):715-20. doi: 10.1200/JCO.1990.8.4.715. J Clin Oncol. 1990. PMID: 1690272

8

Splenectomy in gynecologic oncology: indications, complications, and technique.

Morris M, Gershenson DM, Burke TW, Wharton JT, Copeland LJ, Rutledge FN. Morris M, et al. Gynecol Oncol. 1991 Nov;43(2):118-22. doi: 10.1016/0090-8258(91)90056-b. Gynecol Oncol. 1991. PMID: 1743552

9

Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer.

Jacob JH, Gershenson DM, Morris M, Copeland LJ, Burke TW, Wharton JT. Jacob JH, et al. Among authors: morris m. Gynecol Oncol. 1991 Aug;42(2):146-50. doi: 10.1016/0090-8258(91)90335-3. Gynecol Oncol. 1991. PMID: 1894174

10

Prognostic factors in stage IB squamous cervical cancer patients with low risk for recurrence.

Smiley LM, Burke TW, Silva EG, Morris M, Gershenson DM, Wharton JT. Smiley LM, et al. Among authors: morris m. Obstet Gynecol. 1991 Feb;77(2):271-5. doi: 10.1097/00006250-199102000-00022. Obstet Gynecol. 1991. PMID: 1988891

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,823 results

Search Page

Filters